Why the Mach7 (ASX:M7T) share price is roaring 6% higher today

Mach7's revenues are set for a much welcomed boost.

| More on:
two doctors smile as they sit together at a desk looking at a patient's Xray.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Mach7 Technologies Ltd (ASX: M7T) share price is pushing firmly into positive territory on Tuesday. This comes after the healthcare imaging platform provider announced new sales to an existing client.

At the time of writing, Mach7 shares are up 6.53% to a 2-month high of $1.06.

Mach7 secures purchase orders

While the All Ordinaries Index (ASX: XAO) has fallen 0.63% to 7,338 points, the Mach7 share price has headed north.

According to its announcement, Mach7 advised it has received purchase orders from Trinity Health for an array of its products. These include Mach7 Enterprise Imaging Platform, eUnity Diagnostic Viewer, eUnity Enterprise Viewer, and Mach7 Universal Worklist.

Based in Michigan, Trinity Health is one of the largest multi-institutional Catholic health care delivery systems in the United States. The company services 92 hospitals, as well as 100 continuing care locations that provide care programs and senior living facilities for the elderly.

Mach7 noted the initial purchase orders have a combined value of $3.6 million for software and services. The revenues are expected to be recognised in the current financial year.

In addition, following software deployment, the orders will contribute another $3.8 million in support fees over the next 7 years. In total, this brings the initial contract value to $7.4 million for Mach7.

Mach7 CEO Mike Lampron commented:

I am excited for the opportunity to [partner] with Trinity Health, one of the top healthcare delivery networks in the United States.

I believe the full Mach7 solution is well-positioned to deliver on the strategic objectives of Trinity's Unified Clinical Imaging Platform Strategy and I look forward to being a part of their initiative.

About the Mach7 share price

Over the past 12 months, Mach7 shares have moved sideways to register a 5% loss for the period. Year-to-date also hasn't been great for investors with the company's shares down more than 15% despite today's gain.

Based on the current share price, Mach7 commands a market capitalisation of roughly $251 million with 236.8 million shares outstanding.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended MACH7 FPO. The Motley Fool Australia has recommended MACH7 FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL share price leaping higher amid $1.9 billion funding news

ASX 200 investors are bidding up the CSL share price on Wednesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

Guess which ASX 200 healthcare share is jumping 7% on a guidance update

This healthcare share is performing better than expected in FY 2024.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

1 ASX healthcare stock that looks severely undervalued

I think this stock looks too cheap to miss.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Own Medibank shares? Here's why it's a rewarding day for you

Shareholders are getting a healthy boost today.

Read more »

Health professional looking at a laptop.
Healthcare Shares

Are CSL shares a must-buy in March?

Let's see what analysts are saying about this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

This ASX healthcare stock is up 72% on FDA news and 'historic moment'

Huge gains are been recorded by this stock on Tuesday. But why?

Read more »